
Trump and pharma industry discuss boosting medicine spending abroad to cut US prices, sources say
President Donald Trump has begun levying higher import taxes on dozens of countries, just as the economic fallout of his months-long tariff threats has begun to create visible damage for the US economy.
Just after midnight, goods from more than 60 countries and the European Union (EU) became subject to tariff rates of 10pc or higher.
Products from the European Union, Japan and South Korea are taxed at 15pc, while imports from Taiwan, Vietnam and Bangladesh are taxed at 20pc.
Mr Trump also expects the EU, Japan and South Korea to invest hundreds of billions of dollars in the US.
'I think the growth is going to be unprecedented,' Mr Trump said on Wednesday afternoon.
He added that the US was 'taking in hundreds of billions of dollars in tariffs', but he could not provide a specific figure for revenues because 'we don't even know what the final number is' regarding tariff rates.
Despite the uncertainty, the Trump White House is confident that the onset of his broad tariffs will provide clarity about the path of the world's largest economy.
Now that companies understand the direction the US is headed, the administration believes it can ramp up new investments and jump-start hiring in ways that can rebalance the US economy as a manufacturing power.
But so far, there are signs of self-inflicted wounds to America as companies and consumers alike brace for the impact of new taxes.
What the data has shown is a US economy that changed in April with Mr Trump's initial rollout of tariffs, an event that led to market drama, a negotiating period and Mr Trump's ultimate decision to start his universal tariffs on Thursday.
After April, economic reports show that hiring began to stall, inflationary pressures crept upward and home values in key markets started to decline, said John Silvia, chief executive of Dynamic Economic Strategy.
'A less productive economy requires fewer workers,' Mr Silvia said in an analysis note.
'But there is more, the higher tariff prices lower workers' real wages. The economy has become less productive, and firms cannot pay the same real wages as before. Actions have consequences.'
Even then, the ultimate transformations of the tariffs are unknown and could play out over months, if not years.
Many economists say the risk is that the American economy is steadily eroded rather than collapsing instantly.
'We all want it to be made for television where it's this explosion – it's not like that,' said Brad Jensen, a professor at Georgetown University.
'It's going to be fine sand in the gears and slow things down.'
Mr Trump has promoted the tariffs as a way to reduce the persistent trade deficit.
But importers sought to avoid the taxes by importing more goods before the taxes went into effect.
As a result, the 582.7 billion dollar trade imbalance for the first half of the year was 38pc higher than in 2024.
Total construction spending has dropped 2.9pc over the past year.
The lead-up to Thursday fit the slapdash nature of Mr Trump's tariffs, which have been variously rolled out, walked back, delayed, increased, imposed by letter and frantically renegotiated.
The process has been so muddled that officials for key trade partners were unclear at the start of the week whether the tariffs would begin on Thursday or Friday.
The language of the July 31 order to delay the start of tariffs from August 1 said the higher tax rates would start in seven days.
On Wednesday morning, Kevin Hassett, director of the White House National Economic Council, was asked if the new tariffs began at midnight on Thursday, and he said reporters should check with the US Trade Representative's Office.
Mr Trump on Wednesday announced additional 25pc tariffs to be imposed on India for its buying of Russian oil, bringing its total import taxes to 50pc.
A top body of Indian exporters said on Thursday that the latest US tariffs will impact nearly 55pc of the country's outbound shipments to America and force exporters to lose their long-standing clients.
'Absorbing this sudden cost escalation is simply not viable. Margins are already thin,' SC Ralhan, president of the Federation of Indian Export Organisations, said.
Import taxes are still coming on pharmaceutical drugs and Mr Trump announced 100pc tariffs on computer chips.
That could leave the US economy in a place of suspended animation as it awaits the impact.
The president's use of a 1977 law to declare an economic emergency to impose the tariffs is also under challenge.
The impending ruling from last week's hearing before a US appeals court could cause Mr Trump to find other legal justifications if judges say he exceeded his authority.
Even people who worked with Mr Trump during his first term are sceptical that things will go smoothly for the economy, such as Paul Ryan, the former Republican House of Representatives speaker, who has emerged as a Trump critic.
'There's no sort of rationale for this other than the president wanting to raise tariffs based upon his whims, his opinions,' Mr Ryan told CNBC on Wednesday.
'I think choppy waters are ahead because I think they're going to have some legal challenges.'
Still, the stock market has been solid during the recent tariff drama, with the S&P 500 index climbing more than 25pc from its April low.
The market's rebound and the income tax cuts in Mr Trump's tax and spending measures signed into law on July 4 have given the White House confidence that economic growth is bound to accelerate in the coming months.
As of now, Mr Trump still foresees an economic boom while the rest of the world and American voters wait nervously.
'There's one person who can afford to be cavalier about the uncertainty that he's creating, and that's Donald Trump,' said Rachel West, a senior fellow at The Century Foundation who worked in the Biden White House on labour policy.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Irish Times
10 minutes ago
- Irish Times
Why investors should fear Trump's war on statistics
Donald Trump 's decision to fire Erika McEntarfer, head of the Bureau of Labor Statistics (BLS), for delivering jobs data he didn't like should spook investors. Panmure Liberum's Joachim Klement likens it to Turkish president Recep Tayyip Erdogan's disastrous firing of his chief statistician in 2022. Trump's move is 'extremely dangerous for investors everywhere', says Klement, with truthful economic data being 'the foundation on which investments are built. 'That's echoed by the Friends of BLS campaign. Backed by economists from left and right, it's pushing for McEntarfer's reinstatement and the protection of statistical independence. READ MORE Wall Street banks, too, are spooked, briefing clients that the sacking – defended by Trump as a response to 'rigged' jobs data – undermines the credibility of labour and inflation figures that underpin trillions in assets and guide interest rate decisions. [ Trump's answer to negative economic news: Sack the statistician Opens in new window ] Nearly as alarming as McEntarfer's firing is its defence by White House adviser Kevin Hassett. Once a mainstream Republican economist, Hassett now toes the Trump line. The US government is infested with 'people who have been resisting Trump everywhere they can' and needs 'highly qualified people ... that have a fresh start and a fresh set of eyes on the problem'. Traders on prediction markets Kalshi and Polymarket now see Hassett as the front-runner to replace Jerome Powell as Fed chair, with his odds spiking in recent days. Markets can absorb bad news, but not bad data dressed up as good. If Hassett takes the helm at the Fed, investors will have to worry not just about who reports the numbers, but who acts on them.


Irish Times
40 minutes ago
- Irish Times
Ireland will use EU presidency to advance competitiveness, Tánaiste told Amazon
Tech company Amazon has been told by Tánaiste Simon Harris that Ireland will use its presidency of the European Union next year to 'advance the competitiveness agenda'. Mr Harris also told executives from the online retail and cloud computing giant that Ireland has worked to 'control what we can control' in the current economic climate. This is a key Government message against a backdrop of uncertainty over US trade tariffs on EU goods. Amazon, which employs 6,500 people in Ireland and has invested some €22 billion here since 2004, has been vocal in recent years on the need for Europe to boost its competitiveness. Last month The Irish Times reported that the company has scrapped plans for a €300 million industrial plant in Dublin because it could not secure an electricity supply for the project. READ MORE Mr Harris, the Minister for Foreign Affairs and Trade, met representatives of Amazon in Government buildings on May 21st. A Government note of the meeting was released after a Freedom of Information law request. It says: 'The Tánaiste referenced the current economic climate and listed a number of upcoming initiatives as Ireland worked to control what we can control. Steps in train include the summit on competitiveness and the Action Plan for Competitiveness and Productivity.' The note adds: 'The Tánaiste highlighted Ireland's presidency of the Council of the European Union from July to December 2026 where Ireland will also continue to advance the competitiveness agenda. Developments at EU level were noted including as regards simplification and supporting innovations.' During Ireland's eighth presidency, which it will share with Lithuania and Greece, Irish representatives will chair meetings of EU ministers in the EU Council, steer the council's legislative and policy agenda and lead engagement with other EU institutions. In recent months Amazon has been publicly pushing for measures it argues would improve EU competitiveness. These include easing 'regulatory compliance burdens' for small and medium enterprises (SMEs) regarding producer responsibility recycling schemes that deal with waste items such as packaging and batteries. Recent online posts show Amazon wants digital labelling of products, the 'smooth implementation' of a planned EU VAT 'one-stop shop', and better charging infrastructure for electric commercial vehicles. [ Amazon fiasco is bad news for Ireland Inc Opens in new window ] One of the participants in the meeting between Amazon and Mr Harris, the company's vice-president for EU public policy Lucy C Cronin, wrote last month that the current Danish presidency of the EU has prioritised a 'secure Europe' and a 'competitive and green Europe'. Ms Cronin said the Danish government 'plans to 'focus on regulatory simplification and better regulation in the EU to ease daily operations for businesses and other stakeholders''. She suggested two areas 'where the Danes can turn these aspirations into a meaningful upside for EU SMEs – and therefore EU citizens' are: 'The simplification of fragmented extended producer responsibility (EPR) schemes' and 'the progression toward digital labelling'. Amazon declined to comment on whether it has asked the Irish Government to focus on specific areas during its EU presidency. The other Amazon attendees at the meeting with Mr Harris were vice-president and UK and Ireland country manager John Boumphrey, Amazon country manager for Ireland Alison Dunn and AWS country lead Niamh Gallagher. The note of the meeting says Amazon updated Mr Harris on the launch this year of its Irish store of developments in its cloud computing business, and its climate action initiative. [ Staff at loss-making Amazon subsidiary in Dublin earned average €124,000 last year Opens in new window ] The meeting took place before the deal last month between the EU and US that sees 15 per cent tariffs apply to goods entering the US from the EU. The note says Mr Harris spoke about the Government's 'efforts to support industry' and its trade forum and how that body 'would be happy to engage with Amazon's sector'. Mr Harris is said to have 'highlighted the Government's willingness to work with the sector in navigating the present economic uncertainty'.


Irish Times
40 minutes ago
- Irish Times
How Ireland's economic future is being carved up in talks in the White House
Well you didn't expect it to be straightforward, did you? Irish companies have spent the past few days scrambling to try to understand the impact of Donald Trump's tariffs on their exports to the US and work out what might happen next. Despite the headline deal between the EU and the US, much remains to be settled. In the middle of all this, one thing is clear. Vital negotiations are under way in Washington between big American multinationals and the US president and these are going to have a big impact on Ireland. The State's exposure to a small number of big US firms in terms of corporation tax and employment is well known – so how the big pharma companies and tech giants respond to Trump's cajoling and bullying will be vital. As these deals are being done in Washington, Ireland can only look on. The boss of Apple , one of the Republic's biggest employers and taxpayers, called to the White House this week to pay homage to the chief and promise $100 billion (a nice round number) in new investment in the US - to add to the $500 billion it has already pledged. Analysts, scrambling to work out how this will change the company's structures, believe its chief executive Tim Cook may still be able to retain the supply chains that have guaranteed nice profit margins. How this – or the impact of pressure from Trump on Intel's new chief executive – might affect their Irish operations is far from clear. The best hope is not very much – that the chief executives will pander to Trump a bit, protect as much of their operations as they can and then wait him out. But the point is that Ireland is uniquely vulnerable to decisions made around a dozen US boardrooms and on the interactions of these firms with a volatile and unpredictable president. READ MORE Nowhere is this clearer than in the vital pharma sector. The headlines are about Trump's threats of 150 per cent tariffs in a year or two's time, or maybe 250 per cent, or whatever you are having yourself. The real action is behind the scenes. Here, the big pharma companies are trying to reach an agreement with Trump on pricing in the US market. This is running parallel with his drive to attract the manufacture of key drugs and ingredients back to the US. [ Tariffs: what do Trump's latest pharma threats mean for Ireland? Opens in new window ] As ever with Trump, there are contradictions in the goals he is trying to achieve, so we will have to see where this lands. Trump's tariff threats on pharma run counter to his desire for lower prices. Interestingly, for now EU pharma exports to the US do not look to be facing immediate tariffs. Clarification from US Customs indicates that pharma is on a list to remain zero rated for now, according to Carol Lynch, a customs partner with BDO. However, the sector may well face some charge when Trump announces the results of a separate investigation into the sector shortly. This could be of 15 per cent, though this is not clear. The backdrop to this are the active discussions between the White House and big pharma companies on the pricing issue as part of Trump's agenda to drive down US drug prices – which are notoriously high – to the lowest levels available elsewhere. This could involve the pharma companies charging more in other countries, including in the EU, as a rebalancing exercise. They are also looking for concessions from Europe on the way they are reimbursed for new drugs coming on to the market. [ Irish exporters 'told to shut their mouths' over Trump tariffs Opens in new window ] Unlike the half-baked madness of much of his policy, Trump has a point here. Drug companies have arranged their affairs not only to drag huge profits out of the US market, but also to pay tax on this in countries like Ireland, where the charge is lower. Work by economist Brad Setser of the Council on Foreign Relations in the US shows how the big six US pharma companies combined set aside no funds to pay tax to the US exchequer in 2023. Zero. This is despite the vast bulk of their revenues coming from the US market, where prices are on average almost three times higher than the OECD average, according to a 2022 study undertaken on behalf of the US government, with the biggest gap being for the kind of high-value branded drugs and their ingredients made in Ireland. Ironically, the 2017 tax reforms introduced when Trump was first in office increased the tax incentive for pharma firms to invest abroad and keep some key intellectual property assets in countries like Ireland. Trump's 'big, beautiful bill' – his new tax plan – will do nothing to address this. These trends have been hugely to Ireland's advantage in recent years, but now create a vulnerability, as things that get way out of line generally do. There is a risk of less investment here by pharma over the next few years. And also of changed pricing practices which lead to less profit being declared in Ireland and thus less corporate tax paid here. [ Apple's new investment in US may be just enough to appease Trump, for now at least Opens in new window ] Ireland might settle for some loss here, if Trump held off threats of massive and disruptive tariffs in the years ahead. While the EU feels it has a deal to keep all tariffs to a maximum of 15 per cent, Trump's recent comments suggest he thinks otherwise. But, like in microchips, he might spare those who fall in with his demands to invest in the US – or in the case of pharma cut prices. Trump's direct dealings with big players vital to our economic future adds to the uncertainty about the economic outlook. Tariffs are not the only economic weapon at his disposal. He is also relying on arm-twisting and the 'power' which the US government has via the goods it purchases and its ability to set the ground rules through regulation. That said, big pharma and big tech are powerful players and have cards to play too Ireland won't get to choose how all the deals are worked out. The future shape of the trading world is being carved up in the White House between a capricious president and amoral multinationals who care nothing for his agenda, but will play along in their own interest. Ireland's hope will be that it can continue to position itself as an ongoing trusted supplier and investment home to the US – that we are accepted as part of the supply chain which ends up in the US. The Government will try to diversify trade, too. But we have an awful lot of eggs in Uncle Sam's basket and a lot at stake as Donald Trump tries to get the big multinationals to do his bidding.